Global neuroblastoma drugs market size was valued at USD 1.87 billion in 2024 and is projected to reach USD 3.74 billion by 2032, with a CAGR of 8.90% during the forecast period of 2025 to 2032.  Introduction The neuroblastoma drugs market is a crucial segment of the global oncology industry, focusing on the development, distribution, and use of treatments for neuroblastoma, a rare and...